The goal of the 14th International Lung Cancer Congress® is to provide physicians with practical information regarding tobacco cessation, lung cancer staging, the latest clinical data impacting the treatment of lung cancer, and novel agents and strategies that will shape the future of lung cancer therapy. The importance of personalized therapy will be emphasized, followed by other current topics of interest. State-of-the-art treatment for non–small-cell lung cancer (NSCLC) by stage, SCLC, and mesothelioma will be discussed. Didactic lectures and case-based panel discussions will be used to reinforce current standards and to present emerging clinical data. Panel discussions, multidisciplinary tumor boards, and question-and-answer sessions will allow the faculty to share their personal experiences and opinions on specific clinical scenarios and ongoing controversies in the treatment of lung cancer. Furthermore, a recurring session will highlight clinical research activity of Cooperative Groups in the United States, Europe, and Asia. This will provide invaluable education to the practicing physician to increase their knowledge and improve their performance in managing patients with lung cancer.